In fact, some diabetes treatments including metformin and SGLT2 inhibitors, have displayed cardiovascular benefits highly related to AMPK, although underlying mechanisms of the action are still uncertain [5]. This evidence concerns the gene SLC5A2 and diabetes mellitus.